Section 721.11429 - Halogenated sodium benzoate (generic) (P-19-90)(a)Chemical substance and significant new uses subject to reporting.(1) The chemical substance identified generically as halogenated sodium benzoate (PMN P-19-90) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section.(2) The significant new uses are: (i)Hazard communication. Requirements as specified in § 721.72(a) through (f), (g)(1), (g)(2)(i) through (iii), and (g)(5) . For purposes of § 721.72(e) , the concentration is set at 1.0%. For purposes of § 721.72(g)(1) , this substance may cause: Skin irritation; respiratory complications; central nervous system effects; internal organ effects; reproductive effects; developmental effects; eye irritation. Alternative hazard and warning statements that meet the criteria of the Globally Harmonized System and OSHA Hazard Communication Standard may be used.(ii)Industrial, commercial, and consumer activities. Requirements as specified in § 721.80(k) and (q) . It is a significant new use to manufacture, process, or use the substance other than in a liquid formulation. It is a significant new use to manufacture or process the substance without including the engineering controls/processes described in the premanufacture notice.(b)Specific requirements. The provisions of subpart A of this part apply to this section except as modified by this paragraph (b). (1)Recordkeeping. Recordkeeping requirements as specified in § 721.125(a) through (c) and (f) through (i) are applicable to manufacturers and processors of this substance.(2)Limitation or revocation of certain notification requirements. The provisions of § 721.185 apply to this section.(3)Determining whether a specific use is subject to this section. The provisions of § 721.1725(b)(1) apply to paragraph (a)(2)(ii) of this section. 86 FR 46150 , Aug. 18, 2021